NDC 63323-671-05 - Dexmedetomidine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-671
- Requested NDC
- 63323-671-05
- Package NDCs from labels
- 63323-671-02, 63323-671-20, 63323-671-05, 63323-671-50, 63323-671-01, 63323-671-00
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2024-03-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dexmedetomidine Hydrochloride - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-03-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-671-00 | Dexmedetomidine Hydrochloride | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 5 | |
| 63323-671-01 | Dexmedetomidine Hydrochloride | 100 mL in 1 BOTTLE, GLASS | INJECTION, SOLUTION | 100 | 5 | |
| 63323-671-02 | Dexmedetomidine Hydrochloride | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 5 | |
| 63323-671-05 | Dexmedetomidine Hydrochloride | 50 mL in 1 BOTTLE, GLASS | INJECTION, SOLUTION | 50 | 5 | |
| 63323-671-20 | Dexmedetomidine Hydrochloride | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 5 | |
| 63323-671-50 | Dexmedetomidine Hydrochloride | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-671-00 | ML - Milliliter | 63323-671 | 40beb3f6-7bc2-48d6-933f-201ee2763ffc | 1 | 2019-06-19 |
| 63323-671-01 | ML - Milliliter | 63323-671 | 59fcd655-1d1c-4b59-af8b-d0d4cdc5536b | 1 | 2019-06-19 |
| 63323-671-02 | ML - Milliliter | 63323-671 | bb1dbc22-6c23-4e76-9e6e-4e656842f2f7 | 1 | 2019-06-19 |
| 63323-671-05 | ML - Milliliter | 63323-671 | 6fa96e9c-0fb2-4df4-9be0-b5ffb28f88c2 | 1 | 2019-06-19 |
| 63323-671-20 | ML - Milliliter | 63323-671 | 7ef08756-32f8-4501-9653-40be400a983c | 1 | 2019-06-19 |
| 63323-671-50 | ML - Milliliter | 63323-671 | ffa8f1d9-5954-470e-8537-30660fbece3f | 1 | 2019-06-19 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dexmedetomidine Hydrochloride | DEXMEDETOMIDINE HYDROCHLORIDE | Gland Pharma Limited | f307de7e-a9ab-4734-abb7-66b4e112bc51 | 2026-05-20 | Warnings, Adverse reactions | 1718906 1718909 1018WH7F9I |
| Precedex | DEXMEDETOMIDINE HYDROCHLORIDE | Hospira, Inc. | 548a88c0-afda-427e-75ac-5af0cfa2224c | 2026-05-20 | Warnings, Adverse reactions | 1718906 1718909 1718900 1018WH7F9I |
| DEXMEDETOMIDINE HYDROCHLORIDE | DEXMEDETOMIDINE HYDROCHLORIDE | Mylan Institutional LLC | f140de5a-f13d-46b4-a742-049c63e474f5 | 2026-05-20 | Warnings, Adverse reactions | 1718906 1718909 1018WH7F9I |
| Dexmedetomidine Hydrochloride | DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE | Amneal Pharmaceuticals LLC | 4df8cc35-fc80-4438-b982-9c4b7d17bad2 | 2026-05-19 | Warnings, Adverse reactions | 1718906 1718909 1018WH7F9I |
| Sodium Chloride | SODIUM CHLORIDE | Hospira, Inc. | a2a964f7-c3ec-4dfb-e3a0-6d8136a80397 | 2026-05-19 | Warnings, Adverse reactions | 451W47IQ8X |
| Dexmedetomidine | DEXMEDETOMIDINE | Gland Pharma Limited | 714cc0d2-8a4c-40c0-8ef0-dcfde4c46989 | 2026-05-19 | Warnings, Adverse reactions | 1018WH7F9I |
| Dexmedetomidine | DEXMEDETOMIDINE | Mylan Institutional LLC | ebdfe2e8-30ca-4f18-935a-41bcbbce4937 | 2026-05-18 | Warnings, Adverse reactions | 1018WH7F9I |
| Herplex | ANATHERUM MURICATUM, CLEMATIS ERECTA, MEZEREUM, PHYTOLACCA DECANDRA, RANUNCULUS BULBOSUS, RHUS TOX, THUJA OCCIDENTALIS, NATRUM MURIATICUM, SEPIA | Nashco Products LLC | e5e7aa2f-3697-4747-9045-670ea2b13557 | 2026-05-14 | Warnings | 451W47IQ8X |
| NebuClear MD | SALINE | Blue Echo Care LLC | 3f85fe62-230f-b0f1-e063-6394a90a5cb8 | 2026-05-11 | Warnings | 451W47IQ8X |
| Acne Relief | BELLADONNA, SILICEA, GRAPHITES, HEPAR SULPHURIS CALCAREUM, KALI BROMATUM, LEDUM PALUSTRE, NATRUM MURIATICUM, SELENIUM, SULPHUR | NaturalCare | 487b1373-b78c-4510-964a-6ab0fe781ff4 | 2026-05-08 | Warnings | 451W47IQ8X |
| Migraine Relief | BELLADONNA, BRYONIA (ALBA), CHAMOMILLA, CIMICIFUGA RACEMOSA, COFFEA CRUDA, GLONOINUM, IRIS VERSICOLOR, NATRUM MURIATICUM, PASSIFLORA INCARNATA, VALERIANA OFFICINALIS | The Magni Company | 79b25c52-e145-4ee5-af2e-1ccf6ad5ac2d | 2026-05-07 | Warnings | 451W47IQ8X |
| DEXMEDETOMIDINE HYDROCHLORIDE | DEXMEDETOMIDINE HYDROCHLORIDE | Baxter Healthcare Company | 8ccb45a7-8290-469c-9644-a4dca967d88f | 2026-05-07 | Warnings, Adverse reactions | 1718906 1718909 1018WH7F9I |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, PETROLEUM JELLY, PHENYL BUTAZONE, PLUMBUM METALLICUM, POTASSIUM SORBATE, RESORCINUM, SALICYLICUM ACIDUM, | Energique, Inc. | 2831d28e-9cf1-4a72-9c6c-bb014d059558 | 2026-05-06 | Warnings | Q40Q9N063P |
| Viril | BENZOICUM ACIDUM, CALADIUM SEGUINUM, CHIMAPHILA UMBELLATA, CLEMATIS ERECTA, RHODODENDRON, SABAL SERRULATA, NATRUM MURIATICUM, CORTISONE ACETICUM, HYPOTHALAMUS SUIS, PROSTATE (SUIS), TESTOSTERONE, AGNUS CASTUS, AURUM METALLICUM, BRYONIA (ALBA), CONIUM MACULATUM, LYCOPODIUM CLAVATUM, SELENIUM METALLICUM, SEPIA, THUJA OCCIDENTALIS, KALI ARSENICOSUM, BUFO RANA | Deseret Biologicals, Inc. | 3701cc0d-91ed-45fd-98b8-9d8cfba9c787 | 2026-05-06 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Sportpharm LLC | a2c111f6-74d5-4a5d-82ac-d0f237488cb8 | 2026-04-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Method Pharmaceuticals, LLC | 4b08859e-65bd-8255-e063-6394a90af614 | 2026-04-23 | Warnings | 451W47IQ8X |
| Ringers | SODIUM CHLORIDE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | ICU Medical, Inc. | a926f913-18fa-4a3e-bfd6-210e1e427960 | 2026-04-20 | Warnings, Adverse reactions | 451W47IQ8X |
| Cardioforce II | ABROTANUM, BOLDO, CIMICIFUGA RACEMOSA, KALI PHOSPHORICUM, TARAXACUM OFFICINALE, CONVALLARIA MAJALIS, MAGNESIA SULPHURICA, OLEANDER, NATRUM MURIATICUM, BELLIS PERENNIS | BioActive Nutritional, Inc. | 733bbb26-7698-4a1b-9dc8-7e3490ffc92b | 2026-04-17 | Warnings | 451W47IQ8X |
| Thyroid HP | BARYTA CARBONICA, CALCAREA CARBONICA, FUCUS VESICULOSUS, IODIUM, NATRUM MURIATICUM, PULSATILLA, SPONGIA TOSTA, THYROIDINUM (SUIS) | BioActive Nutritional, Inc. | 3795820a-cf2a-4094-9a02-70e3757b7510 | 2026-04-17 | Warnings | 451W47IQ8X |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.